Author: M. Shaminur Rahman; M. Nazmul Hoque; M. Rafiul Islam; Salma Akter; A. S. M. Rubayet-Ul-Alam; Mohammad Anwar Siddique; Otun Saha; Md. Mizanur Rahaman; Munawar Sultana; M. Anwar Hossain
Title: Epitope-based chimeric peptide vaccine design against S, M and E proteins of SARS-CoV-2 etiologic agent of global pandemic COVID-19: an in silico approach Document date: 2020_3_31
ID: 0yqyclxk_4
Snippet: were not selected as the potential epitope candidate because of their presence in viral 172 transmembrane domains ( Supplementary Fig. 3) . The tertiary structures of the RBD and NTD 173 illustrate their surface-exposed position on the S protein (Fig. 2) . 174 protein possessed only one highly antigenic epitope (57- 194 antigenicity score = 0.449) which might be potentially functional in host cell binding (Table 2) . 195 Furthermore, the Kolaskar.....
Document: were not selected as the potential epitope candidate because of their presence in viral 172 transmembrane domains ( Supplementary Fig. 3) . The tertiary structures of the RBD and NTD 173 illustrate their surface-exposed position on the S protein (Fig. 2) . 174 protein possessed only one highly antigenic epitope (57- 194 antigenicity score = 0.449) which might be potentially functional in host cell binding (Table 2) . 195 Furthermore, the Kolaskar and Tongaonkar antigenicity profiling found five highly antigenic 196 epitopes in RBD region with an average (antigenicity) score of 1.042 (minimum = 0.907, 197 maximum = 1.214), and seven highly antigenic epitopes in NTD with an average (antigenicity) 198 score of 1.023 (minimum = 0.866, maximum = 1.213) ( Supplementary Fig. 4 , Supplementary 199 Table 2 ). The average Kolaskar scores for envelop protein B-cell epitope (EBE) and membrane 200 protein B-cell epitope (MBE) were 0.980 and 1.032, respectively (Supplementary Table 2) . 201
Search related documents:
Co phrase search for related documents- antigenicity score and cell binding: 1, 2
- antigenicity score and epitope candidate: 1
- antigenicity score and Supplementary table: 1, 2
- average antigenicity and Supplementary table: 1
- cell binding and epitope candidate: 1, 2, 3, 4, 5
- cell binding and host cell binding: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76
- cell binding and potential epitope candidate: 1, 2
- cell binding and RBD region: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
- cell binding and Supplementary table: 1, 2
- cell binding and surface expose: 1, 2
- cell binding and tertiary structure: 1, 2, 3, 4
- cell binding and transmembrane domain: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
Co phrase search for related documents, hyperlinks ordered by date